Article Text

Download PDFPDF
Overdiagnosis in lung cancer screening: why modelling is essential

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors KtH and HJdK were responsible for conception and design, analysis and interpretation of the data, drafting of the article, critical revision of the article for important intellectual content and final approval of the article.

  • Funding This publication was indirectly supported by Grant 5U01CA152956-04 from the National Cancer Institute as part of the Cancer Intervention and Surveillance Modelling Network (CISNET).

  • Competing interests KtH and HJdK are members of the Cancer Intervention and Surveillance Modelling Network (CISNET) Lung working group. HJdK is the principal investigator of the Dutch-Belgian Lung Cancer Screening Trial (Nederlands-Leuvens Longkanker Screenings onderzoek; the NELSON trial). KtH is a researcher affiliated with the NELSON trial.

  • Provenance and peer review Commissioned; externally peer reviewed.